1 Sommerburg, O, Keunen, JEE, Bird, AC, et al. (1998) Fruits and vegetables that are sources for lutein and zeaxanthin: the macular pigment in human eyes. Br J Ophthalmol 82, 907–910.
2 Kaplan, LA, Lau, JM & Stein, EA (1990) Carotenoid composition, concentrations, and relationships in various human organs. Clin Physiol Biochem 8, 1–10.
3 Bone, RA, Landrum, JT & Tarsis, SL (1985) Preliminary identification of the human macular pigment. Vision Res 25, 1531–1535.
4 Bone, RA, Landrum, JT, Hime, GW, et al. (1993) Stereochemistry of the human macular carotenoids. Invest Ophthalmol Vis Sci 34, 2033–2040.
5 Congdon, N, O'Colmain, B, Klaver, CC, et al. (2004) Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 122, 477–485.
6 Hollyfield, JG, Bonilha, VL, Rayborn, ME, et al. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14, 194–198.
7 Izumi-Nagai, K, Nagai, N, Ohgami, K, et al. (2007) Macular pigment lutein is antiinflammatory in preventing choroidal neovascularization. Arterioscler Thromb Vasc Biol 27, 2555–2562.
8 Loane, E, Kelliher, C, Beatty, S, et al. (2008) The rationale and evidence base for a protective role of macular pigment in age-related maculopathy. Br J Ophthalmol 92, 1163–1168.
9 Stringham, JM & Hammond, BR Jr (2005) Dietary lutein and zeaxanthin: possible effects on visual function. Nutr Rev 63, 59–64.
10 Caballero, B (2007) The global epidemic of obesity: an overview. Epidemiol Rev 29, 1–5.
11 Hedley, AA, Ogden, CL, Johnson, CL, et al. (2004) Prevalence of overweight and obesity among US children, adolescents, and adults, 1999–2002. JAMA 291, 2847–2850.
12 Parker, RS (1989) Carotenoids in human-blood and tissues. J Nutr 119, 101–104.
13 Hammond, BR, Ciulla, TA & Snodderly, DM (2002) Macular pigment density is reduced in obese subjects. Invest Ophthalmol Vis Sci 43, 47–50.
14 Nolan, J, O'Donovan, O, Kavanagh, H, et al. (2004) Macular pigment and percentage of body fat. Invest Ophthalmol Vis Sci 45, 3940–3950.
15 Peeters, A, Magliano, DJ, Stevens, J, et al. (2008) Changes in abdominal obesity and age-related macular degeneration: the Atherosclerosis Risk in Communities Study. Arch Ophthalmol 126, 1554–1560.
16 Johnson, EJ (2005) Obesity, lutein metabolism, and age-related macular degeneration: a web of connections. Nutr Rev 63, 9–15.
17 Viroonudomphol, D, Pongpaew, P, Tungtrongchitr, R, et al. (2003) The relationships between anthropometric measurements, serum vitamin A and E concentrations and lipid profiles in overweight and obese subjects. Asia Pac J Clin Nutr 12, 73–79.
18 Zwiauer, K, Widhalm, K & Kerbl, B (1990) Relationship between body fat distribution and blood lipids in obese adolescents. Int J Obes 14, 271–277.
19 Berg, CM, Lappas, G, Strandhagen, E, et al. (2008) Food patterns and cardiovascular disease risk factors: the Swedish INTERGENE research program. Am J Clin Nutr 88, 289–297.
20 Kirby, ML, Galea, M, Loane, E, et al. (2009) Foveal anatomic associations with the secondary peak and the slope of the macular pigment spatial profile. Invest Ophthalmol Vis Sci 50, 1383–1391.
21 Loane, E, McKay, GJ, Nolan, JM, et al. (2010) Apolipoprotein E genotype is associated with macular pigment optical density. Invest Ophthalmol Vis Sci 51, 2636–2643.
22 O'Connell, ED, Nolan, JM, Stack, J, et al. (2008) Diet and risk factors for age-related maculopathy. Am J Clin Nutr 87, 712–722.
23 Greenberg, I, Stampfer, MJ, Schwarzfuchs, D, et al. (2009) Adherence and success in long-term weight loss diets: the dietary intervention randomized controlled trial (DIRECT). J Am Coll Nutr 28, 159–168.
24 Frisch, S, Zittermann, A, Berthold, HK, et al. (2009) A randomized controlled trial on the efficacy of carbohydrate-reduced or fat-reduced diets in patients attending a telemedically guided weight loss program. Cardiovasc Diabetol 8, 36.
25 Jehn, ML, Patt, MR, Appel, LJ, et al. (2006) One year follow-up of overweight and obese hypertensive adults following intensive lifestyle therapy. J Hum Nutr Diet 19, 349–354.
26 Azadbakht, L, Mirmiran, P, Esmaillzadeh, A, et al. (2007) Better dietary adherence and weight maintenance achieved by a long-term moderate-fat diet. Br J Nutr 97, 399–404.
27 Sacks, FM, Bray, GA, Carey, VJ, et al. (2009) Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 360, 859–873.
28 Volpe, SL, Kobusingye, H, Bailur, S, et al. (2008) Effect of diet and exercise on body composition, energy intake and leptin levels in overweight women and men. J Am Coll Nutr 27, 195–208.
29 Kirkwood, L, Aldujaili, E & Drummond, S (2007) Effects of advice on dietary intake and/or physical activity on body composition, blood lipids and insulin resistance following a low-fat, sucrose-containing, high-carbohydrate, energy-restricted diet. Int J Food Sci Nutr 58, 383–397.
30 Jenkinson, CM, Doherty, M, Avery, AJ, et al. (2009) Effects of dietary intervention and quadriceps strengthening exercises on pain and function in overweight people with knee pain: randomised controlled trial. BMJ 339, b3170.
31 Nolan, JM, Stack, J, O'Connell, E, et al. (2007) The relationships between macular pigment optical density and its constituent carotenoids in diet and serum. Invest Ophthalmol Vis Sci 48, 571–582.
32 Curran-Celentano, J, Hammond, BR, Ciulla, TA, et al. (2001) Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr 74, 796–802.
33 Nolan, JM, Stack, J, Mellerio, J, et al. (2006) Monthly consistency of macular pigment optical density and serum concentrations of lutein and zeaxanthin. Curr Eye Res 31, 199–213.
34 Trieschmann, M, Beatty, S, Nolan, JM, et al. (2007) Changes in macular pigment optical density and serum concentrations of its constituent carotenoids following supplemental lutein and zeaxanthin: the LUNA study. Exp Eye Res 84, 718–728.
35 Johnson, EJ, Hammond, BR, Yeum, KJ, et al. (2000) Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr 71, 1555–1562.
36 Broekmans, WMR, Berendschot, TTJM, Klopping-Ketelaars, IAA, et al. (2002) Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeaxanthin. Am J Clin Nutr 76, 595–603.
37 Olson, JA (1984) Serum levels of vitamin A and carotenoids as reflectors of nutritional status. J Natl Cancer Inst 73, 1439–1444.
38 Yeum, KJ, Booth, SL, Roubenoff, R, et al. (1998) Plasma carotenoid concentrations are inversely correlated with fat mass in older women. J Nutr Health Aging 2, 79–83.
39 Vioque, J, Weinbrenner, T, Asensio, L, et al. (2007) Plasma concentrations of carotenoids and vitamin C are better correlated with dietary intake in normal weight than overweight and obese elderly subjects. Br J Nutr 97, 977–986.
40 Kant, AK (2003) Interaction of body mass index and attempt to lose weight in a national sample of US adults: association with reported food and nutrient intake, and biomarkers. Eur J Clin Nutr 57, 249–259.
41 Clevidence, BA & Bieri, JG (1993) Association of carotenoids with human plasma lipoproteins. Methods Enzymol 214, 33–46.
42 Berendschot, TT, Plat, J, de Jong, A, et al. (2009) Long-term plant stanol and sterol ester-enriched functional food consumption, serum lutein/zeaxanthin concentration and macular pigment optical density. Br J Nutr 101, 1607–1610.
43 Neuhouser, ML, Rock, CL, Kristal, AR, et al. (2006) Olestra is associated with slight reductions in serum carotenoids but does not markedly influence serum fat-soluble vitamin concentrations. Am J Clin Nutr 83, 624–631.
44 Connor, WE, Duell, PB, Kean, R, et al. (2007) The prime role of HDL to transport lutein into the retina: evidence from HDL-deficient WHAM chicks having a mutant ABCA1 transporter. Invest Ophthalmol Vis Sci 48, 4226–4231.
45 Smith, W, Mitchell, P, Leeder, SR, et al. (1998) Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy – The Blue Mountains Eye Study. Arch Ophthalmol 116, 583–587.
46 Hirvela, H, Luukinen, H, Laara, E, et al. (1996) Risk factors of age-related maculopathy in a population 70 years of age or older. Ophthalmology 103, 871–877.
47 Delcourt, C, Michel, F, Colvez, A, et al. (2001) Associations of cardiovascular disease and its risk factors with age-related macular degeneration: the POLA study. Ophthalmic Epidemiol 8, 237–249.
48 Seddon, JM, Cote, J, Davis, N, et al. (2003) Progression of age-related macular degeneration: associated with body mass index, waist circumference, and waist-hip ratio. Arch Ophthalmol 121, 785–792.